Ibuprofen and indomethacin for the closure of the patent ductus arteriosus

Abstract

The ductus arteriosus connects the pulmonary artery with the aorta and allows right ventricular blood to bypass the unexpanded lungs. In mature infants, the ductus arteriosus closes after birth. Patent ductus arteriosus occurs in 70% of preterm infants with a birth weight < 1,000 grams. Failure of the ductus arteriosus to close has been associated with intraventricular hemorrhage, necrotizing enterocolitis, bronchopulmonary dysplasia, periventricular leukomalacia, renal failure, and persistent pulmonary hypertension. The drugs used to treat the patent ductus arteriosus are ibuprofen and indomethacin which are potent non-selective inhibitors of cyclo-oxygenase (COX) and therefore inhibit prostaglandin E2 synthesis. Prostaglandin E2 relaxes smooth muscle and tends to inhibit the closure of the patent ductus arteriosus. Intravenous ibuprofen and indomethacin inhibit prostaglandin E2 synthesis and thereby close the patent ductus arteriosus with similar efficacy. Indomethacin reduces the blood flow velocity in kidneys, intestine and brain. Ibuprofen has less effect on blood flow velocity in these organs. There is a significant increase in serum creatinine after indomethacin administration but not after ibuprofen and infants treated with ibuprofen have higher creatinine clearance. Oliguria (urine output < 1 ml/kg/h) occurs more frequently with indomethacin than with ibuprofen. Indomethacin requires furosemide for urine output more often than ibuprofen. Ibuprofen reduces the risk of necrotizing enterocolitis and transient renal insufficiency and it is the drug of choice for closing the patent ductus arteriosus. Ibuprofen and indomethacin may be administered orally. In conclusion, intravenous ibuprofen and indomethacin close the patent ductus arteriosus at the same rate, but indomethacin is more toxic than ibuprofen.

Evaluating the Effectiveness of Ibuprofen from 2 Different Brands in Patent Ductus Arteriosus Closure in Preterm Neonates

“…Prostaglandins play an important role in PDA retention. Therefore, cyclooxygenase inhibitors are commonly used to close PDA, and their non-specific cases include indomethacin and ibuprofen (11). Both indomethacin and ibuprofen drugs block arterial duct in 70% of cases; these two drugs compete with arachidonic acid for the reaction site of cyclooxygenase.…”

Perfil Dos Recém-Nascidos Com Diagnóstico De Persistência Do Canal Arterial Em Um Hospital Terciário Do Oeste Paulista

“…Especialmente em prematuros, esta anormalidade resulta em alterações hemodinâmicas graves com consequentes morbidades que afetam os sistemas renal, respiratório e gastrointestinal. Desse modo, o reconhecimento precoce desta patologia é de fundamental importância em virtude da implicação prognóstica pela própria deterioração clínica e da sua alta mortalidade, devendo-se implementar o tratamento o mais rápido possível para prevenir o aparecimento de complicações [4][5][6] .…”